Highlights

[PHARMA] QoQ Annualized Quarter Result on 2011-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 22-Feb-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 31-Dec-2011  [#4]
Profit Trend QoQ -     -2.73%    YoY -     71.66%
Quarter Report


View:


Show?  QoQ % Horiz. %

Annualized Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 1,773,256 1,806,964 1,786,980 1,520,981 1,537,593 1,563,526 1,541,312 9.77%
  QoQ % -1.87% 1.12% 17.49% -1.08% -1.66% 1.44% -
  Horiz. % 115.05% 117.24% 115.94% 98.68% 99.76% 101.44% 100.00%
PBT 132,088 141,146 171,820 73,186 75,757 82,344 87,168 31.83%
  QoQ % -6.42% -17.85% 134.77% -3.39% -8.00% -5.53% -
  Horiz. % 151.53% 161.92% 197.11% 83.96% 86.91% 94.47% 100.00%
Tax -37,856 -50,870 -55,576 -20,401 -21,620 -23,056 -24,772 32.57%
  QoQ % 25.58% 8.47% -172.42% 5.64% 6.23% 6.93% -
  Horiz. % 152.82% 205.35% 224.35% 82.36% 87.28% 93.07% 100.00%
NP 94,232 90,276 116,244 52,785 54,137 59,288 62,396 31.53%
  QoQ % 4.38% -22.34% 120.22% -2.50% -8.69% -4.98% -
  Horiz. % 151.02% 144.68% 186.30% 84.60% 86.76% 95.02% 100.00%
NP to SH 92,860 88,796 114,740 52,157 53,620 58,808 61,936 30.90%
  QoQ % 4.58% -22.61% 119.99% -2.73% -8.82% -5.05% -
  Horiz. % 149.93% 143.37% 185.26% 84.21% 86.57% 94.95% 100.00%
Tax Rate 28.66 % 36.04 % 32.35 % 27.88 % 28.54 % 28.00 % 28.42 % 0.56%
  QoQ % -20.48% 11.41% 16.03% -2.31% 1.93% -1.48% -
  Horiz. % 100.84% 126.81% 113.83% 98.10% 100.42% 98.52% 100.00%
Total Cost 1,679,024 1,716,688 1,670,736 1,468,196 1,483,456 1,504,238 1,478,916 8.80%
  QoQ % -2.19% 2.75% 13.80% -1.03% -1.38% 1.71% -
  Horiz. % 113.53% 116.08% 112.97% 99.28% 100.31% 101.71% 100.00%
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.77%
  QoQ % 3.19% 1.50% -7.80% 10.76% 2.86% 3.14% -
  Horiz. % 113.47% 109.97% 108.34% 117.51% 106.09% 103.14% 100.00%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 39,227 35,301 35,297 35,304 - - - -
  QoQ % 11.12% 0.01% -0.02% 0.00% 0.00% 0.00% -
  Horiz. % 111.11% 99.99% 99.98% 100.00% - - -
Div Payout % 42.24 % 39.76 % 30.76 % 67.69 % - % - % - % -
  QoQ % 6.24% 29.26% -54.56% 0.00% 0.00% 0.00% -
  Horiz. % 62.40% 58.74% 45.44% 100.00% - - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.77%
  QoQ % 3.19% 1.50% -7.80% 10.76% 2.86% 3.14% -
  Horiz. % 113.47% 109.97% 108.34% 117.51% 106.09% 103.14% 100.00%
NOSH 117,683 117,672 117,657 117,682 106,983 106,962 107,007 6.53%
  QoQ % 0.01% 0.01% -0.02% 10.00% 0.02% -0.04% -
  Horiz. % 109.98% 109.97% 109.95% 109.98% 99.98% 99.96% 100.00%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 5.31 % 5.00 % 6.51 % 3.47 % 3.52 % 3.79 % 4.05 % 19.73%
  QoQ % 6.20% -23.20% 87.61% -1.42% -7.12% -6.42% -
  Horiz. % 131.11% 123.46% 160.74% 85.68% 86.91% 93.58% 100.00%
ROE 18.70 % 18.45 % 24.20 % 10.14 % 11.55 % 13.03 % 14.15 % 20.37%
  QoQ % 1.36% -23.76% 138.66% -12.21% -11.36% -7.92% -
  Horiz. % 132.16% 130.39% 171.02% 71.66% 81.63% 92.08% 100.00%
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 1,506.80 1,535.58 1,518.79 1,292.44 1,437.23 1,461.75 1,440.38 3.04%
  QoQ % -1.87% 1.11% 17.51% -10.07% -1.68% 1.48% -
  Horiz. % 104.61% 106.61% 105.44% 89.73% 99.78% 101.48% 100.00%
EPS 78.91 75.46 97.52 44.32 50.12 54.98 57.88 22.88%
  QoQ % 4.57% -22.62% 120.04% -11.57% -8.84% -5.01% -
  Horiz. % 136.33% 130.37% 168.49% 76.57% 86.59% 94.99% 100.00%
DPS 33.33 30.00 30.00 30.00 0.00 0.00 0.00 -
  QoQ % 11.10% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 111.10% 100.00% 100.00% 100.00% - - -
NAPS 4.2200 4.0900 4.0300 4.3700 4.3400 4.2200 4.0900 2.10%
  QoQ % 3.18% 1.49% -7.78% 0.69% 2.84% 3.18% -
  Horiz. % 103.18% 100.00% 98.53% 106.85% 106.11% 103.18% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 135.45 138.03 136.50 116.18 117.45 119.43 117.74 9.76%
  QoQ % -1.87% 1.12% 17.49% -1.08% -1.66% 1.44% -
  Horiz. % 115.04% 117.23% 115.93% 98.68% 99.75% 101.44% 100.00%
EPS 7.09 6.78 8.76 3.98 4.10 4.49 4.73 30.88%
  QoQ % 4.57% -22.60% 120.10% -2.93% -8.69% -5.07% -
  Horiz. % 149.89% 143.34% 185.20% 84.14% 86.68% 94.93% 100.00%
DPS 3.00 2.70 2.70 2.70 0.00 0.00 0.00 -
  QoQ % 11.11% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 111.11% 100.00% 100.00% 100.00% - - -
NAPS 0.3794 0.3676 0.3622 0.3928 0.3547 0.3448 0.3343 8.78%
  QoQ % 3.21% 1.49% -7.79% 10.74% 2.87% 3.14% -
  Horiz. % 113.49% 109.96% 108.35% 117.50% 106.10% 103.14% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 7.5500 10.1800 5.9000 5.3600 5.9000 5.9000 5.7300 -
P/RPS 0.50 0.66 0.39 0.41 0.41 0.40 0.40 15.99%
  QoQ % -24.24% 69.23% -4.88% 0.00% 2.50% 0.00% -
  Horiz. % 125.00% 165.00% 97.50% 102.50% 102.50% 100.00% 100.00%
P/EPS 9.57 13.49 6.05 12.09 11.77 10.73 9.90 -2.23%
  QoQ % -29.06% 122.98% -49.96% 2.72% 9.69% 8.38% -
  Horiz. % 96.67% 136.26% 61.11% 122.12% 118.89% 108.38% 100.00%
EY 10.45 7.41 16.53 8.27 8.49 9.32 10.10 2.29%
  QoQ % 41.03% -55.17% 99.88% -2.59% -8.91% -7.72% -
  Horiz. % 103.47% 73.37% 163.66% 81.88% 84.06% 92.28% 100.00%
DY 4.42 2.95 5.08 5.60 0.00 0.00 0.00 -
  QoQ % 49.83% -41.93% -9.29% 0.00% 0.00% 0.00% -
  Horiz. % 78.93% 52.68% 90.71% 100.00% - - -
P/NAPS 1.79 2.49 1.46 1.23 1.36 1.40 1.40 17.75%
  QoQ % -28.11% 70.55% 18.70% -9.56% -2.86% 0.00% -
  Horiz. % 127.86% 177.86% 104.29% 87.86% 97.14% 100.00% 100.00%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 -
Price 8.2500 8.8300 5.9000 5.9000 5.9000 5.9000 5.0500 -
P/RPS 0.55 0.58 0.39 0.46 0.41 0.40 0.35 35.05%
  QoQ % -5.17% 48.72% -15.22% 12.20% 2.50% 14.29% -
  Horiz. % 157.14% 165.71% 111.43% 131.43% 117.14% 114.29% 100.00%
P/EPS 10.46 11.70 6.05 13.31 11.77 10.73 8.72 12.86%
  QoQ % -10.60% 93.39% -54.55% 13.08% 9.69% 23.05% -
  Horiz. % 119.95% 134.17% 69.38% 152.64% 134.98% 123.05% 100.00%
EY 9.56 8.55 16.53 7.51 8.49 9.32 11.46 -11.35%
  QoQ % 11.81% -48.28% 120.11% -11.54% -8.91% -18.67% -
  Horiz. % 83.42% 74.61% 144.24% 65.53% 74.08% 81.33% 100.00%
DY 4.04 3.40 5.08 5.08 0.00 0.00 0.00 -
  QoQ % 18.82% -33.07% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 79.53% 66.93% 100.00% 100.00% - - -
P/NAPS 1.95 2.16 1.46 1.35 1.36 1.40 1.23 35.85%
  QoQ % -9.72% 47.95% 8.15% -0.74% -2.86% 13.82% -
  Horiz. % 158.54% 175.61% 118.70% 109.76% 110.57% 113.82% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Health minister: Traveller from South Africa on Nov 19 is Malaysia’s first Omicron case save malaysia!
2. WHO urges Asia-Pacific to ready for Omicron-driven surge in infections Good Articles to Share
3. The case of ATA IMS: A tip of the iceberg? By Veeriah save malaysia!
4. 3QCY21 Results Review - Fat Tails Kenanga Research & Investment
5. Aurelius Technologies Bhd - Global EMS Provider PublicInvest Research
6. Strategy - A decent 3Q2021 but uncertainty has increased AmInvest Research Reports
7. MIDF Research maintains 'buy' recommendation on FGV, target price unchanged at RM2.20 (FANTASTIC: ALL PALM OIL STOCKS SHOULD RE RERATED, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
8. Latest Land Disposal in Sg Tiram, Johor, shows Palm Oil Companies with Huge Landbanks with Cheap Book Value are Jewels, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

362  474  546  892 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VSOLAR 0.015-0.005 
 VS 1.15-0.27 
 THHEAVY 0.015-0.05 
 VS-WB 0.355-0.09 
 IMPIANA 0.085+0.005 
 INARI 3.87-0.23 
 GOCEAN 0.0350.00 
 DNEX 0.745-0.025 
 ATAIMS 0.445+0.035 
 EAH 0.02+0.005 
PARTNERS & BROKERS